Safety and Tolerability of COMBIVENT® HFA as Compared to COMBIVENT® CFC and Placebo HFA in Healthy Male and Female Subjects
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to assess the safety and tolerability of COMBIVENT® hydrofluoroalkane (HFA) as compared
to COMBIVENT® chlorofluorocarbons (CFC) and placebo HFA after single and repetitive dosing in
healthy male and female subjects